phase II clinical study
BC Cancer Foundation Launches C$6.8M Campaign to Advance CAR T-Cell Therapies
The foundation hopes to put the funds toward two clinical programs in blood cancers and one preclinical project in solid tumors.
Restore Vision Doses First Retinitis Pigmentosa Patient in Phase I/II Gene Therapy Trial
The Tokyo-based biotech firm expects RV-001 to be able to alter light sensitivity for patients with limited or no vision regardless of genotype.
FDA Clears Lion TCR to Begin Phase II Trial of TCR T-Cell Therapy in HBV-Related Liver Cancer
The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.
Bicara Therapeutics Begins Trial of Ficerafusp Alfa, Keytruda in First-Line Head and Neck Cancer
The Phase II/III trial will include patients with PD-L1-positive tumors and who are HPV-negative.
Immuneering Partners with Regeneron to Study Combined MEK, PD-1 Inhibitor Therapy in Solid Tumors
Regeneron will supply Libtayo within an ongoing Phase II trial of Immuneering's MEK inhibitor.